Ercem Atillasoy - 25 Jan 2022 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role: Officer Title: Chief Regulatory and Safety Officer
Signature: /s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol: KLRS
Transactions as of: 25 Jan 2022
Net transactions value: -$38,248
Form type: 4
Filing time: 26 Jan 2022, 15:15:28 UTC
Previous filing: 04 Apr 2022
Next filing: 22 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALVR	Common Stock	Sale	$38,248	-4,639	-4.4%	$8.24	100,347	25 Jan 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.10 to $8.46. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Remarks:

Officer Title: Chief Regulatory and Safety Officer